Sapna Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.00 Cr
- Satisfied Charges ₹ 11.50 Cr
- Revenue Growth -6.06%
- Profit Growth 22.50%
- Ebitda 36.34%
- Net Worth 2.54%
- Total Assets 9.58%
About Sapna Pharmaceuticals
Sapna Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 March 2011 and has a history of 13 years and ten months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹13.00 Cr. The company has closed loans amounting to ₹11.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tinu Kothari and Susheela Kothari serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230KA2011PTC057887
-
Company No.
057887
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Mar 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Sapna Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tinu Kothari
|
Director | 06-Mar-2015 | Current |
|
Susheela Kothari
|
Director | 20-Mar-2023 | Current |
Financial Performance of Sapna Pharmaceuticals.
Sapna Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.06% decrease. The company also saw a substantial improvement in profitability, with a 22.5% increase in profit. The company's net worth moved up by a moderate rise of 2.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sapna Pharmaceuticals?
In 2023, Sapna Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹13.00 Cr
₹11.50 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 10.00 Cr
- Development Credit Bank Limited : 3.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Oct 2022 | Hdfc Bank Limited | ₹10.00 Cr | Open |
| 29 Jul 2011 | Development Credit Bank Limited | ₹3.00 Cr | Open |
| 23 Mar 2015 | Yes Bank Limited | ₹6.50 Cr | Satisfied |
| 09 Feb 2013 | Ing Vysya Bank Limited | ₹5.00 Cr | Satisfied |
How Many Employees Work at Sapna Pharmaceuticals?
Sapna Pharmaceuticals has a workforce of 24 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sapna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapna Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
